AstraZeneca
AZN
£52.60
Share price
-1.87%
Change (1 day)
-12.67%
Change (1 year)
Categories
Revenue for AstraZeneca (AZN)
Revenue in 2025 (TTM): £42.75 Billion
According to AstraZeneca's latest financial reports the company's current revenue (TTM 
) is £41.07 Billion. In 2024 the company made a revenue of £43.08 Billion an increase over the revenue in the year 2023 that were of £35.95 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for AstraZeneca from 1996 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | £42.75 B | -0.78% |
| 2024 | £43.08 B | 19.83% |
| 2023 | £35.95 B | -1.91% |
| 2022 | £36.65 B | 32.25% |
| 2021 | £27.71 B | 41.95% |
| 2020 | £19.52 B | 5.01% |
| 2019 | £18.59 B | 6.85% |
| 2018 | £17.40 B | 4.69% |
| 2017 | £16.62 B | -10.83% |
| 2016 | £18.64 B | 11.81% |
| 2015 | £16.67 B | -2.1% |
| 2014 | £17.02 B | 9.26% |
| 2013 | £15.58 B | -9.94% |
| 2012 | £17.30 B | -19.92% |
| 2011 | £21.61 B | 0.28% |
| 2010 | £21.55 B | 6.31% |
| 2009 | £20.27 B | -5.98% |
| 2008 | £21.56 B | 44.91% |
| 2007 | £14.87 B | 10.08% |
| 2006 | £13.51 B | -2.68% |
| 2005 | £13.88 B | 24.44% |
| 2004 | £11.16 B | 5.92% |
| 2003 | £10.53 B | -4.25% |
| 2002 | £11.00 B | -32.19% |
| 2001 | £16.23 B | 33.72% |
| 2000 | £12.13 B | 6.38% |
| 1999 | £11.40 B | 93.09% |
| 1998 | £5.90 B | 8.39% |
| 1997 | £5.45 B | -18.31% |
| 1996 | £6.67 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Bristol-Myers Squibb BMY | £35.58 B | -13.36% | 🇺🇸 USA |
 Pfizer PFE | £46.66 B | 13.61% | 🇺🇸 USA |
 Merck MRK | £47.75 B | 16.26% | 🇺🇸 USA |
 GlaxoSmithKline GSK | £30.32 B | -26.18% | 🇬🇧 UK |
 Sanofi SNY | £35.41 B | -13.79% | 🇫🇷 France |
 Eli Lilly LLY | £36.61 B | -10.87% | 🇺🇸 USA |
 Johnson & Johnson JNJ | £66.74 B | 62.47% | 🇺🇸 USA |
 Abbott Laboratories ABT | £31.63 B | -22.99% | 🇺🇸 USA |
 Biogen BIIB | £7.33 B | -82.15% | 🇺🇸 USA |
 Novartis NVS | £39.76 B | -3.20% | 🇨🇭 Switzerland |